- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Profitable Climbers
Hong Kong Pharmaceuticals & Biotech Profitable Climbers
Results
11
11 companies
WuXi XDC Cayman
Market Cap: HK$63.9b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$56.15
7D
0.6%
1Y
40.4%
Biocytogen Pharmaceuticals (Beijing)
Market Cap: HK$33.8b
A biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally.
2315
HK$54.45
7D
-1.2%
1Y
249.5%
RemeGen
Market Cap: HK$62.6b
A biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States.
9995
HK$91.15
7D
-0.1%
1Y
347.9%
CanSino Biologics
Market Cap: HK$12.7b
Develops, manufactures, and commercializes vaccines in the People’s Republic of China.
6185
HK$32.32
7D
-4.9%
1Y
-2.8%
JBM (Healthcare)
Market Cap: HK$2.1b
An investment holding company, engages in the manufacture, marketing, distribution, and sale of branded healthcare and wellness products in Hong Kong, Macau, Mainland China, and internationally.
2161
HK$2.65
7D
-3.3%
1Y
47.2%
Consun Pharmaceutical Group
Market Cap: HK$13.4b
Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.
1681
HK$16.27
7D
-4.8%
1Y
83.8%
Innovent Biologics
Market Cap: HK$134.5b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.
1801
HK$81.55
7D
-2.9%
1Y
108.3%
Luye Pharma Group
Market Cap: HK$9.3b
Develops, produces, markets, and sells pharmaceutical products in the People’s Republic of China, the United States, Europe, and internationally.
2186
HK$2.30
7D
-7.3%
1Y
1.3%
Beijing Tong Ren Tang Chinese Medicine
Market Cap: HK$6.6b
Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals.
3613
HK$7.84
7D
-8.3%
1Y
-8.6%
Simcere Pharmaceutical Group
Market Cap: HK$28.6b
An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China.
2096
HK$11.19
7D
-6.8%
1Y
48.8%
China Medical System Holdings
Market Cap: HK$31.7b
An investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China.
867
HK$12.95
7D
-0.08%
1Y
75.7%